MedPath

Restoring Upright Mobility After Spinal Cord Injury

Not Applicable
Completed
Conditions
Spinal Cord Diseases
Spinal Cord Injuries
Registration Number
NCT04262414
Lead Sponsor
University Health Network, Toronto
Brief Summary

Up to 15 able-bodied individuals will participate in one testing session to evaluate the effectiveness of the A-FES system. Up to 20 individuals with SCI will participate in 12 sessions of A-FES therapy. At each session, participants will stand on a force plate (Accu Sway, AMTI, USA) with the A-FES system (Compex Motion II, Compex Motion, Switzerland) donned. The centre of pressure (COP) will be calculated in real time using the force plate data. The calculated COP will be presented to participants on a monitor and they will be instructed to shift their COP in the indicated directions as represented by a cursor (i.e. training with visual feedback). The intensity of electrical stimulation provided by the A-FES system will be regulated by the measured COP in a closed-loop manner. In this study we propose to develop and evaluate the clinically-feasible A-FES system for the training of standing balance.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
5
Inclusion Criteria
  1. A traumatic or non-traumatic, non-progressive (AIS) C or D SCI;
  2. ≥18 years old;
  3. Able to stand independently for 60s;
  4. Moderate level of trunk control as evidenced by the ability to reach forward >2 inches in standing (i.e. score of 2 on the BBS Reaching Forward task50,51); and
  5. Free of any other condition besides SCI that significantly affects walking or balance (e.g., no vestibular disorder, significant vision loss, stroke).
Read More
Exclusion Criteria
  1. Severe spasticity in the legs;
  2. Contractures in the lower extremities that prevent achieving a neutral hip and ankle position, or extended knee;
  3. A prior lower extremity fragility fracture;
  4. An injection of botulinum toxin to leg muscles in the past six months;
  5. Peripheral nerve damage in the legs (i.e. leg muscles unresponsive to electrical stimulation);
  6. A pressure sore (>grade 2) on the pelvis or trunk where the safety harness is applied; o
  7. Contraindications for FES52 (i.e. implanted electronic device, active cancer or radiation in past 6 months, epilepsy, skin rash/wound at a potential electrode site).

Participants will be withdrawn from the study if FES irritates their skin.

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Mini-Balance Evaluation Systems TestChange from Baseline Mini-Balance Evaluation Systems Test at 8 weeks

Assesses four balance control systems, including anticipatory balance, reactive postural control, sensory orientation and dynamic gait

Activities-specific Balance Confidence ScaleChange from Baseline Activities-specific Balance Confidence Scale at 8 weeks

A measure of balance self-efficacy; mean score of 0-100; higher score means a better outcome (i.e. high balance confidence)

Berg Balance ScaleChange from Baseline Berg Balance Scale at 8 weeks

Assesses static and dynamic standing balance; score 0-56; higher score means a better outcome

Secondary Outcome Measures
NameTimeMethod
Static standing balanceThrough study completion, average of 8 weeks

Postural sway during quiet standing

Dynamic standing balanceThrough study completion, average of 8 weeks

Assessed by asking participants to lean as far as possible in the forward, backward and sideways directions while standing on a force plate (i.e. limits of stability test)

Semi-structured interviewup to 8 weeks post-intervention

The guide will include open-ended questions concerning the participant's experience with, and impressions of, A-FES therapy

Trial Locations

Locations (1)

Lyndhurst Centre, Toronto Rehabilitation Institute-UHN

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath